NCT04888728View on ClinicalTrials.gov

To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2021

Primary Completion Date

July 12, 2021

Study Completion Date

July 27, 2021

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

DWN12088

Prolyl-tRNA synthetase (PRS) inhibitor

DRUG

Nebivolol

Nebivolol

DRUG

Paroxetine

Paroxetine

Trial Locations (1)

47397

Inje University Busan Paik Hospital, Busan

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

NCT04888728 - To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers | Biotech Hunter | Biotech Hunter